Alexion's Acquisition of Synageva
Scroll to keep reading
Matthew Hurd, Legal counsel to Synageva
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion’s business in treatments for rare diseases.
Alexion’s takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock.
FinanceMesirow Financial’s Chief Economist says a profound shift has occurred in American consumer confidence.
InnovationDeveloping economies quickened the pace of their business reforms during the last 12 months to make it easier for local businesses to start and operate, says the World Bank Group’s annual ease of doing business measurement.
InnovationWith DeepMind claiming that its AI system – AlphaCode – can “write computer code at a competitive level,” a milestone may have been reached. The ability of a machine to match the coding skills typical of human intelligence, if true, represents a moment
FinanceDuring the third quarter of 2015, small businesses and middle market companies appear to be less optimistic as the year comes to a close and many are in the midst of budget planning.
FinanceUnlike many of its competitors, which focus on numbers, Chantler Kent Investments focuses on finding out what its clients want to accomplish during their lifetime and builds profitable portfolios with dreams in mind.
LegalMaclay Murray & Spens Advises Phoenix Fund Services During Maitland's Acquisition
InnovationWhen you run a professional options trading business, you gain the right to buy or sell assets at a set price prior to a specific date. These days, investors can begin options trading from home. Do it right, and you could end up with healthy profits.
FinanceDrawing on more than an aggregated 100 years of local investment experience in the Brazilian market, Prudent Group, through its innovative Prudent Investment Fund (PIF), offers investors a unique opportunity to move into this dynamic market. Having recently be
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
